AN2 Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
24.00
|
|
Average Rating
|
2.80
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-0.39
|
-0.35
|
0.03
|
8.97%
|
|
2024-06-30
|
-0.59
|
-0.48
|
0.11
|
18.99%
|
|
2024-03-31
|
-0.62
|
-0.56
|
0.06
|
9.68%
|
|
2023-12-31
|
-0.75
|
-0.57
|
0.18
|
24.00%
|
|
2023-09-30
|
-0.63
|
-0.65
|
-0.02
|
-3.17%
|
|
2023-06-30
|
-0.85
|
-0.81
|
0.04
|
4.71%
|
|
2023-03-31
|
-0.68
|
-0.79
|
-0.11
|
-16.18%
|
|
2022-12-31
|
-0.65
|
-0.61
|
0.04
|
6.15%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-1.39
|
|
2023-12-31
|
-2.82
|
|
2022-12-31
|
-4.71
|
|
2021-12-31
|
0.00
|